Health Canada
www.hc-sc.gc.ca
Common menu bar links
Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2013-1969
2. Registrant Information.
Registrant Reference Number: 03152013- MCPA
Registrant Name (Full Legal Name no abbreviations): MCPA Task Force Three (members: Nufarm bv, Dow AgroSciences, Albaugh Inc.)
Address: 44 Tamarack Circle
City: Toronto
Prov / State: Ontario
Country: CANADA
Postal Code: M9P 3T9
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)PMRA Registration No. PMRA Submission No. 2005-4106 EPA Registration No.
Product Name: MCPA Acid
- Active Ingredient(s)
- MCPA (PRESENT AS ACID)
7. b) Type of formulation.
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title Incident Report Submission transmitting copy of 6a2 Notice for BASF Dermal Penetration Studies titled "Study on the Retention of 14C MCPA in Rat Skin after Dermal Administration of Dilutions of the Formulation MCPA DMA 750 g/l AI" and "14C MCPA - Study on the Dermal Penetration in Rats after Repeated Dermal Application"
Date 13-MAR-13
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
New health or environmental hazard
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
These studies show that for formulations of MCPA, there is no substantial evidence that material retained at the application site on the skin may be subsequently absorbed. At least 50% of the radioactivity remaining after initial decontamination of the application site was still within the skin after 14 days. Where measured, the majority of the radioactivity lost from the site was associated with surface sloughing with no evidence for systemic absorption. For MCPA, even with the most conservative assumptions, no more than 50% of radioactivity found at the application site should be included with material potentially absorbed.
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
Unknown
